Aurora Cannabis Inc is having a tough trading day as its stock price drops significantly.
Aurora Cannabis Inc (ACB.TO) is down 3.61% today, closing at CA$5.08. This decline reflects ongoing struggles in the cannabis sector, especially as the company adjusts to changes in both domestic and international markets.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$339.98M
52W high
$9.33
52W low
$3.59
1W change
-3.24%
Beta
1.34
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 0.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.38
+0.2% Upside
Current Price
C$5.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
72.5%
Annualized
90-Day Vol
54.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$6.42
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$5.70 | C$4.44 โ C$7.32 |
| 60 trading days | C$6.05 | C$4.25 โ C$8.62 |
| 90 trading days | C$6.42 | C$4.16 โ C$9.90 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should stay cautious. Aurora's recent performance highlights the volatility and challenges in the cannabis industry, particularly with declining revenues and market share.
Aurora Cannabis Inc's stock drops 3.61% today
With a market cap of CA$327.67 million, Aurora's stock decline shows the pressures cannabis companies face amid changing market dynamics.
Bull case
If Aurora can successfully shift its focus to international medical cannabis sales, it may stabilize its revenue streams and improve profitability over time.
Bear case
Ongoing declines in Canadian medical cannabis revenue and the company's retreat from consumer cannabis could further hurt Aurora's market position and investor confidence.
Current Performance Overview
Advertisement
Aurora Cannabis Inc's stock is down 3.61% today, closing at CA$5.08. This decline reflects broader challenges in the cannabis market, particularly as Aurora deals with a significant drop in Canadian medical cannabis revenue, which fell 25% due to changes in federal reimbursement rates.
Market Dynamics Impacting Aurora
The cannabis sector is undergoing significant changes, with Aurora shifting its focus toward international markets. While international medical cannabis sales saw a 17% increase, the overall revenue dropped by 9% year-over-year, indicating a troubling trend. Investors should be aware of how these dynamics may continue to affect Aurora's stock performance.
Looking Ahead
As Aurora Cannabis Inc navigates its current challenges, the company's ability to adapt to market demands and focus on higher-return medical markets will be crucial. Investors should keep a close eye on developments, especially given the ongoing volatility in the cannabis sector. For more insights, check out our detailed analysis on Aurora Cannabis Inc.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
